History and Perspectives of A2AAdenosine Receptor Antagonists as Potential Therapeutic Agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
History and Perspectives of A2AAdenosine Receptor Antagonists as Potential Therapeutic Agents
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 35, Issue 4, Pages 790-848
Publisher
Wiley
Online
2015-03-28
DOI
10.1002/med.21344
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JNJ-40255293, a Novel Adenosine A2A/A1 Antagonist with Efficacy in Preclinical Models of Parkinson’s Disease
- (2014) John R. Atack et al. ACS Chemical Neuroscience
- Optimization of 6-Heterocyclic-2-(1H-pyrazol-1-yl)-N-(pyridin-2-yl)pyrimidin-4-amine as Potent Adenosine A2A Receptor Antagonists for the Treatment of Parkinson’s Disease
- (2014) Jiyue Zheng et al. ACS Chemical Neuroscience
- 8-Substituted 2-alkynyl-N9-propargyladenines as A2A adenosine receptor antagonists
- (2014) Kazuki Endo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Adenosine A2A Receptor Antagonists in Parkinson’s Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued
- (2014) Annalisa Pinna CNS DRUGS
- The Dopamine D2 and Adenosine A2A Receptors: Past, Present and Future Trends for the Treatment of Parkinson’s Disease
- (2014) M. Jorg et al. CURRENT MEDICINAL CHEMISTRY
- Towards Next Generation Adenosine A2A Receptor Antagonists
- (2014) G. Yuan et al. CURRENT MEDICINAL CHEMISTRY
- 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies
- (2014) Lucia Squarcialupi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity
- (2014) Rakesh Yadav et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- l-DOPA disrupts adenosine A2A–cannabinoid CB1–dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
- (2014) Annalisa Pinna et al. EXPERIMENTAL NEUROLOGY
- Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
- (2014) Santiago Perez-Lloret et al. EXPERT OPINION ON PHARMACOTHERAPY
- Adenosine Receptors: Expression, Function and Regulation
- (2014) Sandeep Sheth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synthesis and Pharmacological Evaluation of Dual Acting Ligands Targeting the Adenosine A2A and Dopamine D2 Receptors for the Potential Treatment of Parkinson’s Disease
- (2014) Manuela Jörg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of [18F]-Labeled Pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) Analogs for the Imaging of Cerebral Adenosine A2A Receptors with Positron Emission Tomography
- (2014) Shivashankar Khanapur et al. JOURNAL OF MEDICINAL CHEMISTRY
- Scaffold Decoration at Positions 5 and 8 of 1,2,4-Triazolo[1,5-c]Pyrimidines to Explore the Antagonist Profiling on Adenosine Receptors: A Preliminary Structure–Activity Relationship Study
- (2014) Stephanie Federico et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neuroprotective Potential of Adenosine A2Aand Cannabinoid CB1Receptor Antagonists in an Animal Model of Parkinson Disease
- (2014) Silvia Cerri et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys
- (2014) O. Barret et al. JOURNAL OF NUCLEAR MEDICINE
- Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
- (2014) Marla Rivera-Oliver et al. LIFE SCIENCES
- AdenosineA2AReceptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
- (2014) Felicita Pedata et al. MEDIATORS OF INFLAMMATION
- Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
- (2014) Cyril Laurent et al. NEUROBIOLOGY OF AGING
- Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease
- (2014) Stefka Gyoneva et al. NEUROBIOLOGY OF DISEASE
- Emerging therapies for Parkinson's disease: From bench to bedside
- (2014) F.I. Tarazi et al. PHARMACOLOGY & THERAPEUTICS
- Structural and Energetic Effects of A2A Adenosine Receptor Mutations on Agonist and Antagonist Binding
- (2014) Henrik Keränen et al. PLoS One
- Structure-based drug design of chromone antagonists of the adenosine A2A receptor
- (2014) Stephen P. Andrews et al. MedChemComm
- Computational Prediction of Alanine Scanning and Ligand Binding Energetics in G-Protein Coupled Receptors
- (2014) Lars Boukharta et al. PLoS Computational Biology
- Adenosine, adenosine receptors and glaucoma: An updated overview
- (2013) Yisheng Zhong et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Design and evaluation of xanthine based adenosine receptor antagonists: Potential hypoxia targeted immunotherapies
- (2013) Rhiannon Thomas et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases
- (2013) Pierre Koch et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists
- (2013) Brian C. Shook et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists
- (2013) Zhaohui Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Adenosine A2A Receptor Antagonists as Positron Emission Tomography (PET) Tracers
- (2013) S. Khanapur et al. CURRENT MEDICINAL CHEMISTRY
- Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
- (2013) W. J. Geldenhuys et al. CURRENT MEDICINAL CHEMISTRY
- Istradefylline: First Global Approval
- (2013) Rosselle Dungo et al. DRUGS
- Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease
- (2013) Susan H. Fox DRUGS
- Preladenant, a selective adenosine A2A receptor antagonist, is not associated with QT/QTc prolongation
- (2013) Z. Wang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Adenosine 2A receptor promotes collagen production by human fibroblasts via pathways involving cyclic AMP and AKT but independent of Smad2/3
- (2013) Miguel Perez-Aso et al. FASEB JOURNAL
- Synthesis of (E)-8-(3-Chlorostyryl)caffeine Analogues Leading to 9-Deazaxanthine Derivatives as Dual A2A Antagonists/MAO-B Inhibitors
- (2013) Silvia Rivara et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones
- (2013) Anne Stößel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adenosine A2A Receptor as a Drug Discovery Target
- (2013) Manuel de Lera Ruiz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of Metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), A Potent Antagonist of the A2A Adenosine Receptor for the Treatment of Parkinson’s Disease
- (2013) Giovanni Piersanti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
- (2013) Stewart A. Factor et al. MOVEMENT DISORDERS
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Adenosine receptors as drug targets — what are the challenges?
- (2013) Jiang-Fan Chen et al. NATURE REVIEWS DRUG DISCOVERY
- 8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A2A receptor antagonist
- (2013) Namrata Kumari et al. NEUROSCIENCE LETTERS
- Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results
- (2013) Hubert H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- Adenosine receptors as potential targets in melanoma
- (2013) Antonella Montinaro et al. PHARMACOLOGICAL RESEARCH
- Cardiovascular adenosine receptors: Expression, actions and interactions
- (2013) John P. Headrick et al. PHARMACOLOGY & THERAPEUTICS
- A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
- (2013) Sofia Cristóvão-Ferreira et al. Purinergic Signalling
- Adenosine: setting the stage for plasticity
- (2013) Raquel B. Dias et al. TRENDS IN NEUROSCIENCES
- Adenosine A2A receptors promote collagen production by a Fli1- and CTGF-mediated mechanism
- (2013) Edwin SL Chan et al. ARTHRITIS RESEARCH & THERAPY
- Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
- (2012) L. Pisani et al. CURRENT MEDICINAL CHEMISTRY
- Pharmacological blockade of adenosine A2A receptors diminishes scarring
- (2012) Miguel Perez-Aso et al. FASEB JOURNAL
- Crude caffeine reduces memory impairment and amyloid β1–42 levels in an Alzheimer’s mouse model
- (2012) Yi-Fang Chu et al. FOOD CHEMISTRY
- Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects
- (2012) D. L. Cutler et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Effect of adenosine A2A receptor antagonist ZM241385 on amygdala-kindled seizures and progression of amygdala kindling
- (2012) Xiang Li et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Design and Characterization of Optimized Adenosine A2A/A1 Receptor Antagonists for the Treatment of Parkinson's Disease
- (2012) Brian C. Shook et al. JOURNAL OF MEDICINAL CHEMISTRY
- Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists
- (2012) Pier Giovanni Baraldi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening
- (2012) Christopher J. Langmead et al. JOURNAL OF MEDICINAL CHEMISTRY
- Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications
- (2012) Pier Giovanni Baraldi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design
- (2012) Miles Congreve et al. JOURNAL OF MEDICINAL CHEMISTRY
- Benzothiazinones: A Novel Class of Adenosine Receptor Antagonists Structurally Unrelated to Xanthine and Adenine Derivatives
- (2012) Michael Gütschow et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Conjugated Agent between Dopamine and an A2A Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach
- (2012) Alessandro Dalpiaz et al. MOLECULAR PHARMACEUTICS
- Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
- (2012) Lorraine V. Kalia et al. MOVEMENT DISORDERS
- Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?
- (2012) V. Kumar Purinergic Signalling
- Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
- (2012) W. Liu et al. SCIENCE
- Structure–Activity Relationships and Molecular Modeling of 1,2,4-Triazoles as Adenosine Receptor Antagonists
- (2012) Jens Carlsson et al. ACS Medicinal Chemistry Letters
- Adenosine A2A Receptor Antagonists and Parkinson’s Disease
- (2011) Brian C. Shook et al. ACS Chemical Neuroscience
- Adenosine A2A and A2B receptors are both required for adenosine A1 receptor-mediated cardioprotection
- (2011) Enbo Zhan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists
- (2011) Pier Giovanni Baraldi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones
- (2011) Joel M. Harris et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Caffeine induces beneficial changes in PKA signaling and JNK and ERK activities in the striatum and cortex of Alzheimer's transgenic mice
- (2011) Ross Zeitlin et al. BRAIN RESEARCH
- Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
- (2011) Adam T. Waickman et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Substructure-Based Virtual Screening for Adenosine A2A Receptor Ligands
- (2011) Eelke van der Horst et al. ChemMedChem
- Differential neuroprotection by A1 receptor activation and A2A receptor inhibition following pilocarpine-induced status epilepticus
- (2011) Fernanda Elisa Rosim et al. EPILEPSY & BEHAVIOR
- Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson’s disease
- (2011) F. Stocchi et al. EUROPEAN JOURNAL OF NEUROLOGY
- Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A1 receptors
- (2011) Jana Sawynok et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Future Treatments for Parkinson's Disease: Surfing the PD Pipeline
- (2011) Robert A. Hauser INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Discovery of Phosphoric Acid Mono-{2-[(E/Z)-4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-benzoylimino]-thiazol-3-ylmethyl} Ester (Lu AA47070): A Phosphonooxymethylene Prodrug of a Potent and Selective hA2AReceptor Antagonist
- (2011) Anette G. Sams et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A2AAdenosine Receptor Antagonists with Improved Water Solubility
- (2011) Stephanie Federico et al. JOURNAL OF MEDICINAL CHEMISTRY
- Production of functional recombinant G-protein coupled receptors for heteromerization studies
- (2011) Milena Čavić et al. JOURNAL OF NEUROSCIENCE METHODS
- Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
- (2011) Guillaume Lebon et al. NATURE
- Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study
- (2011) Emmanuelle Pourcher et al. PARKINSONISM & RELATED DISORDERS
- The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery
- (2011) J. A. Salon et al. PHARMACOLOGICAL REVIEWS
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
- (2011) Marie Therese Armentero et al. PHARMACOLOGY & THERAPEUTICS
- The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade
- (2011) Lyndsey E. Collins et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Structure of an Agonist-Bound Human A2A Adenosine Receptor
- (2011) F. Xu et al. SCIENCE
- Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
- (2011) Andrew S. Doré et al. STRUCTURE
- Aminomethyl substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists
- (2011) Brian C. Shook et al. MedChemComm
- The role of adenosine receptors in rheumatoid arthritis
- (2010) Katia Varani et al. AUTOIMMUNITY REVIEWS
- Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
- (2010) Catarina V. Gomes et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Recent developments in adenosine receptor ligands and their potential as novel drugs
- (2010) Christa E. Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A2A receptor antagonists
- (2010) Chandra Bhushan Mishra et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Optimization of arylindenopyrimidines as potent adenosine A2A/A1 antagonists
- (2010) Brian C. Shook et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists
- (2010) Bidhan A. Shinkre et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthetic studies on selective adenosine A2A receptor antagonists. Part II: Synthesis and structure–activity relationships of novel benzofuran derivatives
- (2010) Osamu Saku et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Methylene amine substituted arylindenopyrimidines as potent adenosine A2A/A1 antagonists
- (2010) Brian C. Shook et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers
- (2010) David J. Brooks et al. CLINICAL NEUROPHARMACOLOGY
- Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors
- (2010) A. Llach et al. EUROPEAN HEART JOURNAL
- Adenosine receptors as drug targets
- (2010) Bertil B. Fredholm EXPERIMENTAL CELL RESEARCH
- Adenosine A2AReceptor Signaling and GolfAssembly Show a Specific Requirement for the γ7Subtype in the Striatum
- (2010) William F. Schwindinger et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Vivo Characterization of a Dual Adenosine A2A/A1Receptor Antagonist in Animal Models of Parkinson’s Disease
- (2010) Brian C. Shook et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Discovery of Novel Chemotypes for Adenosine A2AReceptor Antagonists
- (2010) Vsevolod Katritch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Discovery of A2AAdenosine Receptor Ligands
- (2010) Jens Carlsson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission
- (2010) Alberto Martire et al. JOURNAL OF NEUROCHEMISTRY
- Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
- (2010) K. J. Black et al. JOURNAL OF NEUROSCIENCE
- Contribution of Adenosine A2A and A2B Receptors to Ischemic Coronary Dilation: Role of KV and KATP Channels
- (2010) ZACHARY C BERWICK et al. MICROCIRCULATION
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- A long-term study of istradefylline in subjects with fluctuating Parkinson's disease
- (2010) Stewart Factor et al. PARKINSONISM & RELATED DISORDERS
- Neuroprotective and anti-inflammatory effects of the adenosine A2A receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease
- (2010) Lucia Frau et al. SYNAPSE
- Normalization of A2Aand A3adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor α but not methotrexate
- (2009) Katia Varani et al. ARTHRITIS AND RHEUMATISM
- Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist–antagonist binding modulation
- (2009) Vicent Casadó et al. BIOCHEMICAL PHARMACOLOGY
- Antagonists of the human A2A receptor. Part 6: Further optimization of pyrimidine-4-carboxamides
- (2009) Roger J. Gillespie et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists
- (2009) Yuefei Shao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antagonists of the human A2A receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides
- (2009) Roger J. Gillespie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of novel 7-imino-2-thioxo-3,7-dihydro-2H-thiazolo [4,5-d] pyrimidine derivatives as adenosine A2A receptor antagonists
- (2009) Pratibha Mehta Luthra et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthetic studies on selective adenosine A2A receptor antagonists: Synthesis and structure–activity relationships of novel benzofuran derivatives
- (2009) Osamu Saku et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons
- (2009) Rita Pepponi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Novel investigational adenosine A2Areceptor antagonists for Parkinson's disease
- (2009) Annalisa Pinna EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A2A adenosine receptor overexpression and functionality, as well as TNF-α levels, correlate with motor symptoms in Parkinson’s disease
- (2009) Katia Varani et al. FASEB JOURNAL
- N-[6-Amino-2-(heteroaryl)pyrimidin-4-yl]acetamides as A2AReceptor Antagonists with Improved Drug Like Properties and in Vivo Efficacy
- (2009) Marion C. Lanier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adenosine A2AReceptor-Antagonist/Dopamine D2Receptor-Agonist Bivalent Ligands as Pharmacological Tools to Detect A2A-D2Receptor Heteromers
- (2009) Aroa Soriano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Remodeling of striatal NMDA receptors by chronic A2A receptor blockade in Huntington's disease mice
- (2009) Alberto Martire et al. NEUROBIOLOGY OF DISEASE
- Adenosine A2A receptor is a unique angiogenic target of HIF-2 in pulmonary endothelial cells
- (2009) A. Ahmad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPCR 3D homology models for ligand screening: Lessons learned from blind predictions of adenosine A2a receptor complex
- (2009) Vsevolod Katritch et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- A novel adenosine A1 and A2A receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: Comparison with existing anti-Parkinson's disease drugs
- (2008) Takuma Mihara et al. BEHAVIOURAL BRAIN RESEARCH
- Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues
- (2008) Judey Pretorius et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A2A antagonists with reduced hERG liability
- (2008) Manisha Moorjani et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists
- (2008) Xiaohu Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives
- (2008) Roger J. Gillespie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A2A antagonists with improved solubility and metabolic stability
- (2008) Manisha Moorjani et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Biaryl and heteroaryl derivatives of SCH 58261 as potent and selective adenosine A2A receptor antagonists
- (2008) Unmesh Shah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis, and evaluation of fused heterocyclic analogs of SCH 58261 as adenosine A2A receptor antagonists
- (2008) Unmesh Shah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives
- (2008) Roger J. Gillespie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antagonists of the human adenosine A2A receptor. Part 3: Design and synthesis of pyrazolo[3,4-d]pyrimidines, pyrrolo[2,3-d]pyrimidines and 6-arylpurines
- (2008) Roger J. Gillespie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potent and selective adenosine A2A receptor antagonists: 1,2,4-Triazolo[1,5-c]pyrimidines
- (2008) Bernard R. Neustadt et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility
- (2008) Pier Giovanni Baraldi et al. CHEMICAL REVIEWS
- A Critical Evaluation of Adenosine A2A Receptors as Potentially “Druggable” Targets in Huntingtons Disease
- (2008) Patrizia Popoli et al. CURRENT PHARMACEUTICAL DESIGN
- Adenosine A2A Receptor Blockade or Deletion Diminishes Fibrocyte Accumulation in the Skin in a Murine Model of Scleroderma, Bleomycin-induced Fibrosis
- (2008) Majid Katebi et al. INFLAMMATION
- Identification of Novel, Water-Soluble, 2-Amino-N-pyrimidin-4-yl Acetamides as A2AReceptor Antagonists with In Vivo Efficacy
- (2008) Deborah H. Slee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-Amino-N-pyrimidin-4-ylacetamides as A2AReceptor Antagonists: 2. Reduction of hERG Activity, Observed Species Selectivity, and Structure−Activity Relationships
- (2008) Deborah H. Slee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-Amino-N-pyrimidin-4-ylacetamides as A2AReceptor Antagonists: 1. Structure−Activity Relationships and Optimization of Heterocyclic Substituents
- (2008) Deborah H. Slee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lead Optimization of 4-Acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2AAdenosine Receptor Antagonists for the Treatment of Parkinson’s Disease
- (2008) Xiaohu Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-Amino-6-furan-2-yl-4-substituted Nicotinonitriles as A2AAdenosine Receptor Antagonists
- (2008) Monica Mantri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antagonists of the Human A2AAdenosine Receptor. 4. Design, Synthesis, and Preclinical Evaluation of 7-Aryltriazolo[4,5-d]pyrimidines
- (2008) Roger J. Gillespie et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology of Parkinson’s disease
- (2008) Guido Alves et al. JOURNAL OF NEUROLOGY
- Brain Adenosine A2A Receptor Occupancy by a Novel A1/A2A Receptor Antagonist, ASP5854, in Rhesus Monkeys: Relationship to Anticataleptic Effect
- (2008) T. Mihara et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Properties of a New Water-Soluble Prodrug of the Adenosine A2A Receptor Antagonist MSX-2
- (2008) Karl Vollmann et al. MOLECULES
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- (2008) György Haskó et al. NATURE REVIEWS DRUG DISCOVERY
- Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease
- (2008) Jacobus P. Petzer et al. Neurotherapeutics
- The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist
- (2008) V.-P. Jaakola et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now